Virtu Financial’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,956
Closed -$343K 1813
2026
Q1
$343K Buy
13,956
+5,532
+66% +$144K 0.01% 753
2025
Q4
$228K Buy
+8,424
New +$227K 0.01% 963
2023
Q4
Sell
-22,261
Closed -$493K 1704
2023
Q3
$493K Buy
+22,261
New +$533K 0.05% 354

Other funds holding FMED

Virtu Financial's FMED Position: Q2 2026 in Review

Virtu Financial sold out of Fidelity Disruptive Medicine ETF (FMED) in Q2 2026, closing a stake of 13,956 shares — an estimated $343K sold.

Virtu Financial first reported a position in FMED in Q3 2023 and held it in 3 quarters. The position peaked at $493K in Q3 2023. 11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Virtu Financial reported no remaining Fidelity Disruptive Medicine ETF position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 13,956 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $343K.
  • Virtu Financial first reported a position in Fidelity Disruptive Medicine ETF in Q3 2023 and held it in 3 quarters.
  • Virtu Financial's Fidelity Disruptive Medicine ETF position peaked at $493K in Q3 2023.
  • 11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.